1. Home
  2. BLTE vs FFIN Comparison

BLTE vs FFIN Comparison

Compare BLTE & FFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$147.72

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo First Financial Bankshares Inc.

FFIN

First Financial Bankshares Inc.

HOLD

Current Price

$30.10

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLTE
FFIN
Founded
2018
1890
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
4.9B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
BLTE
FFIN
Price
$147.72
$30.10
Analyst Decision
Strong Buy
Hold
Analyst Count
9
8
Target Price
★ $228.89
$35.43
AVG Volume (30 Days)
133.0K
★ 985.5K
Earning Date
11-09-2026
10-15-2026
Dividend Yield
N/A
★ 2.90%
EPS Growth
N/A
★ 13.46
EPS
N/A
★ 1.00
Revenue
N/A
N/A
Revenue This Year
N/A
$9.47
Revenue Next Year
N/A
$5.50
P/E Ratio
★ N/A
$30.25
Revenue Growth
N/A
N/A
52 Week Low
$90.84
$28.12
52 Week High
$200.00
$36.52

Technical Indicators

Market Signals
Indicator
BLTE
FFIN
Relative Strength Index (RSI) 39.67 36.26
Support Level $145.21 $28.12
Resistance Level $161.08 $30.21
Average True Range (ATR) 5.89 0.73
MACD -0.37 -0.05
Stochastic Oscillator 30.70 20.94

Price Performance

Historical Comparison
BLTE
FFIN

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About FFIN First Financial Bankshares Inc.

First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.

Share on Social Networks: